Loading…
Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain)
Abstract Reported cases of meningococcal disease between 1997 and 2008 were analyzed to determine the evolution after the introduction of a conjugated vaccine. In
Saved in:
| Published in: | Vaccine 2009-05, Vol.27 (25), p.3496-3498 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c541t-e6cfe92385fb005603ea8b19c6e5b49d0164e0e50f5b17f5b2af19ceef0719043 |
|---|---|
| cites | |
| container_end_page | 3498 |
| container_issue | 25 |
| container_start_page | 3496 |
| container_title | Vaccine |
| container_volume | 27 |
| creator | Martínez, Ana I Dominguez, Angela Oviedo, Manuel Minguell, Sofia Jansa, Josep M Codina, Gemma Vazquez, Julio A |
| description | Abstract Reported cases of meningococcal disease between 1997 and 2008 were analyzed to determine the evolution after the introduction of a conjugated vaccine. In |
| doi_str_mv | 10.1016/j.vaccine.2009.01.045 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_746228753</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X09001297</els_id><sourcerecordid>3500076921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-e6cfe92385fb005603ea8b19c6e5b49d0164e0e50f5b17f5b2af19ceef0719043</originalsourceid><addsrcrecordid>eNqFkt-K1DAUxoso7rj6CEpB1BV2xnPSJk1uFBn8Bwsiq-BdSNPT3YydZGzagb3zHXxDn8SUKS7sxXqTXOT3fTnnfCfLHiOsEFC82qz2xlrnacUA1ApwBSW_ky1QVsWScZR3swUwUS5LhO9H2YMYNwDAC1T3syNUSSRRLLIv60vjLyjmzufDJeW0D904uODz0OZb8s5fBBusNV3euEgm0mmetPjn1-_J4jRfm8F0wTuTn5zvjPMvH2b3WtNFejTfx9m39---rj8uzz5_-LR-e7a0vMRhScK2pFgheVunugQUZGSNygridama1GNJQBxaXmOVDmba9ErUQoUKyuI4e3Hw3fXh50hx0FsXLXWd8RTGqKtSMCYrXiTy-a2kqJhQKCfw5FYQOUAlpVBVQp_eQDdh7H1qWKNgXJagpEoUP1C2DzH21Opd77amv9IIeopRb_Qco55i1IA6xZh0T2b3sd5Sc62ac0vAsxkwMWXT9sZbF_9xDKtSSS4T9-bAUUpi76jX0TrylhrXkx10E9x_S3l9w8F2zrv06Q-6onjdtY5Mgz6fdm5aOVBpS1ia1F9jOs9K</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1625840989</pqid></control><display><type>article</type><title>Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain)</title><source>ScienceDirect Freedom Collection</source><creator>Martínez, Ana I ; Dominguez, Angela ; Oviedo, Manuel ; Minguell, Sofia ; Jansa, Josep M ; Codina, Gemma ; Vazquez, Julio A</creator><creatorcontrib>Martínez, Ana I ; Dominguez, Angela ; Oviedo, Manuel ; Minguell, Sofia ; Jansa, Josep M ; Codina, Gemma ; Vazquez, Julio A ; the Meningococcal Disease Working Group of Catalonia ; Meningococcal Disease Working Group of Catalonia</creatorcontrib><description>Abstract Reported cases of meningococcal disease between 1997 and 2008 were analyzed to determine the evolution after the introduction of a conjugated vaccine. In <6 years, the incidence rate of serogroup C fell from 7.6 to 0.6 per 100,000 persons/year in the periods before (1997–2000) and after (2001–2007) the introduction of the conjugate vaccine. In serogroup B, the reduction was from 15.4 to 11.1. In <20 years case-fatality-rate increased only in serogroup B (3% and 7.4%, p = 0.026). Serosubtype P1.15 was the most frequent in serogroup B (31%), mainly associated with serotype 4 (80%), and in serogroup C subtype P1.5 (36%), with serosubtype 2a (86%). Exhaustive surveillance of circulating meningococcal strains is essential.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2009.01.045</identifier><identifier>PMID: 19200816</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Allergy and Immunology ; Applied microbiology ; Biological and medical sciences ; Case-fatality-rate ; Child ; Child, Preschool ; Children & youth ; Epidemiology ; Evolution ; Fundamental and applied biological sciences. Psychology ; Humans ; Immunization ; Incidence ; Infant ; Infant, Newborn ; Meningitis ; Meningococcal disease ; Meningococcal Infections - epidemiology ; Meningococcal Infections - prevention & control ; Microbiology ; Middle Aged ; Neisseria meningitidis ; Neisseria meningitidis - classification ; Serotyping ; Spain - epidemiology ; Teenagers ; Time Factors ; Vaccination ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><ispartof>Vaccine, 2009-05, Vol.27 (25), p.3496-3498</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Limited May 26, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-e6cfe92385fb005603ea8b19c6e5b49d0164e0e50f5b17f5b2af19ceef0719043</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21749858$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19200816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martínez, Ana I</creatorcontrib><creatorcontrib>Dominguez, Angela</creatorcontrib><creatorcontrib>Oviedo, Manuel</creatorcontrib><creatorcontrib>Minguell, Sofia</creatorcontrib><creatorcontrib>Jansa, Josep M</creatorcontrib><creatorcontrib>Codina, Gemma</creatorcontrib><creatorcontrib>Vazquez, Julio A</creatorcontrib><creatorcontrib>the Meningococcal Disease Working Group of Catalonia</creatorcontrib><creatorcontrib>Meningococcal Disease Working Group of Catalonia</creatorcontrib><title>Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain)</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Reported cases of meningococcal disease between 1997 and 2008 were analyzed to determine the evolution after the introduction of a conjugated vaccine. In <6 years, the incidence rate of serogroup C fell from 7.6 to 0.6 per 100,000 persons/year in the periods before (1997–2000) and after (2001–2007) the introduction of the conjugate vaccine. In serogroup B, the reduction was from 15.4 to 11.1. In <20 years case-fatality-rate increased only in serogroup B (3% and 7.4%, p = 0.026). Serosubtype P1.15 was the most frequent in serogroup B (31%), mainly associated with serotype 4 (80%), and in serogroup C subtype P1.5 (36%), with serosubtype 2a (86%). Exhaustive surveillance of circulating meningococcal strains is essential.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Allergy and Immunology</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Case-fatality-rate</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children & youth</subject><subject>Epidemiology</subject><subject>Evolution</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Immunization</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Meningitis</subject><subject>Meningococcal disease</subject><subject>Meningococcal Infections - epidemiology</subject><subject>Meningococcal Infections - prevention & control</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Neisseria meningitidis</subject><subject>Neisseria meningitidis - classification</subject><subject>Serotyping</subject><subject>Spain - epidemiology</subject><subject>Teenagers</subject><subject>Time Factors</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkt-K1DAUxoso7rj6CEpB1BV2xnPSJk1uFBn8Bwsiq-BdSNPT3YydZGzagb3zHXxDn8SUKS7sxXqTXOT3fTnnfCfLHiOsEFC82qz2xlrnacUA1ApwBSW_ky1QVsWScZR3swUwUS5LhO9H2YMYNwDAC1T3syNUSSRRLLIv60vjLyjmzufDJeW0D904uODz0OZb8s5fBBusNV3euEgm0mmetPjn1-_J4jRfm8F0wTuTn5zvjPMvH2b3WtNFejTfx9m39---rj8uzz5_-LR-e7a0vMRhScK2pFgheVunugQUZGSNygridama1GNJQBxaXmOVDmba9ErUQoUKyuI4e3Hw3fXh50hx0FsXLXWd8RTGqKtSMCYrXiTy-a2kqJhQKCfw5FYQOUAlpVBVQp_eQDdh7H1qWKNgXJagpEoUP1C2DzH21Opd77amv9IIeopRb_Qco55i1IA6xZh0T2b3sd5Sc62ac0vAsxkwMWXT9sZbF_9xDKtSSS4T9-bAUUpi76jX0TrylhrXkx10E9x_S3l9w8F2zrv06Q-6onjdtY5Mgz6fdm5aOVBpS1ia1F9jOs9K</recordid><startdate>20090526</startdate><enddate>20090526</enddate><creator>Martínez, Ana I</creator><creator>Dominguez, Angela</creator><creator>Oviedo, Manuel</creator><creator>Minguell, Sofia</creator><creator>Jansa, Josep M</creator><creator>Codina, Gemma</creator><creator>Vazquez, Julio A</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20090526</creationdate><title>Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain)</title><author>Martínez, Ana I ; Dominguez, Angela ; Oviedo, Manuel ; Minguell, Sofia ; Jansa, Josep M ; Codina, Gemma ; Vazquez, Julio A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-e6cfe92385fb005603ea8b19c6e5b49d0164e0e50f5b17f5b2af19ceef0719043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Allergy and Immunology</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Case-fatality-rate</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children & youth</topic><topic>Epidemiology</topic><topic>Evolution</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Immunization</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Meningitis</topic><topic>Meningococcal disease</topic><topic>Meningococcal Infections - epidemiology</topic><topic>Meningococcal Infections - prevention & control</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Neisseria meningitidis</topic><topic>Neisseria meningitidis - classification</topic><topic>Serotyping</topic><topic>Spain - epidemiology</topic><topic>Teenagers</topic><topic>Time Factors</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martínez, Ana I</creatorcontrib><creatorcontrib>Dominguez, Angela</creatorcontrib><creatorcontrib>Oviedo, Manuel</creatorcontrib><creatorcontrib>Minguell, Sofia</creatorcontrib><creatorcontrib>Jansa, Josep M</creatorcontrib><creatorcontrib>Codina, Gemma</creatorcontrib><creatorcontrib>Vazquez, Julio A</creatorcontrib><creatorcontrib>the Meningococcal Disease Working Group of Catalonia</creatorcontrib><creatorcontrib>Meningococcal Disease Working Group of Catalonia</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martínez, Ana I</au><au>Dominguez, Angela</au><au>Oviedo, Manuel</au><au>Minguell, Sofia</au><au>Jansa, Josep M</au><au>Codina, Gemma</au><au>Vazquez, Julio A</au><aucorp>the Meningococcal Disease Working Group of Catalonia</aucorp><aucorp>Meningococcal Disease Working Group of Catalonia</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain)</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2009-05-26</date><risdate>2009</risdate><volume>27</volume><issue>25</issue><spage>3496</spage><epage>3498</epage><pages>3496-3498</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract Reported cases of meningococcal disease between 1997 and 2008 were analyzed to determine the evolution after the introduction of a conjugated vaccine. In <6 years, the incidence rate of serogroup C fell from 7.6 to 0.6 per 100,000 persons/year in the periods before (1997–2000) and after (2001–2007) the introduction of the conjugate vaccine. In serogroup B, the reduction was from 15.4 to 11.1. In <20 years case-fatality-rate increased only in serogroup B (3% and 7.4%, p = 0.026). Serosubtype P1.15 was the most frequent in serogroup B (31%), mainly associated with serotype 4 (80%), and in serogroup C subtype P1.5 (36%), with serosubtype 2a (86%). Exhaustive surveillance of circulating meningococcal strains is essential.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>19200816</pmid><doi>10.1016/j.vaccine.2009.01.045</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2009-05, Vol.27 (25), p.3496-3498 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_746228753 |
| source | ScienceDirect Freedom Collection |
| subjects | Adolescent Adult Aged Allergy and Immunology Applied microbiology Biological and medical sciences Case-fatality-rate Child Child, Preschool Children & youth Epidemiology Evolution Fundamental and applied biological sciences. Psychology Humans Immunization Incidence Infant Infant, Newborn Meningitis Meningococcal disease Meningococcal Infections - epidemiology Meningococcal Infections - prevention & control Microbiology Middle Aged Neisseria meningitidis Neisseria meningitidis - classification Serotyping Spain - epidemiology Teenagers Time Factors Vaccination Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) |
| title | Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain) |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A00%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20the%20evolution%20of%20meningococcal%20disease,%202001%E2%80%932008,%20Catalonia%20(Spain)&rft.jtitle=Vaccine&rft.au=Mart%C3%ADnez,%20Ana%20I&rft.aucorp=the%20Meningococcal%20Disease%20Working%20Group%20of%20Catalonia&rft.date=2009-05-26&rft.volume=27&rft.issue=25&rft.spage=3496&rft.epage=3498&rft.pages=3496-3498&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2009.01.045&rft_dat=%3Cproquest_cross%3E3500076921%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c541t-e6cfe92385fb005603ea8b19c6e5b49d0164e0e50f5b17f5b2af19ceef0719043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1625840989&rft_id=info:pmid/19200816&rfr_iscdi=true |